Prudential Financial Inc Fate Therapeutics Inc Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

A detailed history of Prudential Financial Inc transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Prudential Financial Inc holds 356,601 shares of FATE stock, worth $713,202. This represents 0.0% of its overall portfolio holdings.

Number of Shares

356,601

Previous 356,101 0.14%

Holding current value

$713,202

Previous $1.17 Million 6.85%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.12 - $5.57 $1,560 - $2,785	500 Added 0.14%	356,601 $1.25 Million
Q2 2024 Aug 13, 2024	SELL	$3.26 - $7.08 $88,346 - $191,868	-27,100 Reduced 7.07%	356,101 $1.17 Million
Q1 2024 May 14, 2024	SELL	$3.54 - $8.35 $625,907 - $1.48 Million	-176,810 Reduced 31.57%	383,201 $2.81 Million
Q4 2023 Feb 13, 2024	BUY	$1.65 - $3.94 $602,415 - $1.44 Million	365,100 Added 187.32%	560,011 $2.09 Million
Q3 2023 Nov 13, 2023	BUY	$2.02 - $5.04 $259,772 - $648,144	128,600 Added 193.93%	194,911 $413,000
Q2 2023 Aug 11, 2023	SELL	$4.76 - $6.59 $445,536 - $616,824	-93,600 Reduced 58.53%	66,311 $315,000
Q1 2023 May 12, 2023	BUY	$4.24 - $11.12 $678,022 - $1.78 Million	159,911 New	159,911 $911,000
Q2 2022 Aug 15, 2022	SELL	$17.78 - $42.39 $120,299 - $286,810	-6,766 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$29.67 - $60.28 $1,839 - $3,737	-62 Reduced 0.91%	6,766 $262,000
Q4 2021 Feb 14, 2022	SELL	$47.84 - $64.34 $3.17 Million - $4.26 Million	-66,188 Reduced 90.65%	6,828 $408,000
Q3 2021 Nov 15, 2021	SELL	$59.27 - $95.73 $89,734 - $144,935	-1,514 Reduced 2.03%	73,016 $4.42 Million
Q2 2021 Aug 16, 2021	BUY	$67.25 - $92.52 $642,573 - $884,028	9,555 Added 14.71%	74,530 $6.47 Million
Q1 2021 May 12, 2021	SELL	$72.16 - $117.4 $292,464 - $475,822	-4,053 Reduced 5.87%	64,975 $5.36 Million
Q4 2020 Feb 16, 2021	BUY	$38.09 - $100.95 $556,990 - $1.48 Million	14,623 Added 26.88%	69,028 $6.28 Million
Q3 2020 Nov 16, 2020	SELL	$30.41 - $40.5 $80,890 - $107,730	-2,660 Reduced 4.66%	54,405 $2.18 Million
Q2 2020 Aug 12, 2020	SELL	$20.21 - $35.23 $400,036 - $697,342	-19,794 Reduced 25.75%	57,065 $1.96 Million
Q1 2020 May 12, 2020	BUY	$17.28 - $31.88 $3,801 - $7,013	220 Added 0.29%	76,859 $1.71 Million
Q4 2019 Feb 11, 2020	BUY	$13.39 - $20.73 $1.03 Million - $1.59 Million	76,639 New	76,639 $1.5 Million

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $194M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Fate Therapeutics Inc Transaction History